ADD ANI AS A TRUSTED SOURCE
googleads
Menu
General News

Paras Hospital becomes first in Gurugram to perform PIPAC for advanced abdominal cancers

Gurugram (Haryana) [India], July 12 (ANI): Paras Hospital in Gurugram became first in the city to perform Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) on a patient who had run out of options after her ovarian cancer recurred for the third time.

ANI Jul 12, 2020 18:38 IST googleads

Paras Healthcare

Gurugram (Haryana) [India], July 12 (ANI): Paras Hospital in Gurugram became first in the city to perform Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) on a patient who had run out of options after her ovarian cancer recurred for the third time.
A 35-year-old Rupshikha Thakur (name changed), whose body had stopped responding to traditional treatment after undergoing cycles of strenuous chemotherapy, targeted therapy and immunotherapy, became the first to undergo the procedure in the millennium city under the expert team of surgical oncologists led by Dr Vinay Samuel Gaikwad, Associate Director, Surgical Oncology, Paras Cancer Centre.
Dr Vinay said that PIPAC is a palliative option of treatment for patients suffering from ovarian, gastric, colorectal, appendicular and certain other cancers which have spread within the abdomen.
"The PIPAC process is a combination of surgery and chemotherapy. This is a laparoscopic procedure in which a keyhole (incision) is made. Using a special device, standard liquid chemotherapy that has been converted into gaseous/aerosol form is sprayed directly onto the cancerous area. After the procedure, the residual fumes are absorbed through a special filter and the incision is closed. In fact, after the procedure, the patient can be discharged on the same day or the next," Dr. Vinay said.
What makes this procedure unique is that it can be used when other treatment fails. Also, the patient's general condition does not have to be very good in order to tolerate the procedure.
"Side-effects that are commonly seen in other procedures such as hair loss, kidney problems, liver problems, vomiting etc, are either minimal or not seen at all. Any patient with peritoneal cancer, who can withstand a two-hour surgery under anesthesia, is compatible with this therapy. Therefore, most patients can tolerate this procedure very well," he said. (ANI)

Get the App

What to Read Next

General News

ED attaches 31 immovable properties worth Rs 581.65 crore in...

ED attaches 31 immovable properties worth Rs 581.65 crore in...

The attached properties are in the form of land parcels situated in Goa, Kerala, Karnataka, Punjab, Tamil Nadu, Uttar Pradesh, Haryana, Jharkhand, Maharashtra, Delhi, West Bengal, Andhra Pradesh, and Rajasthan.

Read More
General News

Maharashtra: Green Corridor movement saves life of woman

Maharashtra: Green Corridor movement saves life of woman

The Green corridor between Thane and Mumbai allowed for the organ to leave from Jupiter Hospital in Thane at 13:45 and reach Nanavati Hospital at 14:16, covering a distance of 26 kilometres in just 30 minutes.

Read More
General News

Successful births using umbilical cord stem cell therapy in India

Successful births using umbilical cord stem cell therapy in India

The pioneering work has been carried out by the Centre of IVF and Human Reproduction in collaboration with the Department of Biotechnology and Research at the hospital.

Read More
General News

"When our car hit pothole, she started breathing," says Husband

In an interesting turn of events, a woman who was declared 'brain-dead' at a hospital in Bareilly, came back to life after a car she was travelling in struck a pothole, as her husband claimed on Wednesday.

Read More
General News

ED raids 19 places in Chandigarh in Rs 590 crore IDFC First bank

ED raids 19 places in Chandigarh in Rs 590 crore IDFC First bank

The Enforcement Directorate (ED) on Wednesday conducted searches at 19 premises in Chandigarh, Haryana and Punjab in relation to the recent fraud that happened at IDFC First Bank, Chandigarh branch, officials said.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.